It is becoming increasingly clear that CIN and DNA damage can trigger IL-6/STAT3 signaling in various cancer types, including breast cancer (Kettner et al. 2019; Hong et al. 2022; Vasiyani et al. 2022) and ovarian cancer (Zhang et al. 2021). Here, IL6 is linked to cancer.